scholarly journals Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma

JAMA Oncology ◽  
2020 ◽  
Vol 6 (2) ◽  
pp. 281 ◽  
Author(s):  
Frederick L. Locke ◽  
William Y. Go ◽  
Sattva S. Neelapu
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy

2019 ◽  
Vol 25 (11) ◽  
pp. e344-e351 ◽  
Author(s):  
Michael Byrne ◽  
Olalekan O. Oluwole ◽  
Bipin Savani ◽  
Navneet S. Majhail ◽  
Brian T. Hill ◽  
...  
Keyword(s):  
T Cell ◽  
Cell Therapy ◽  
B Cell ◽  
Chimeric Antigen Receptor ◽  
Cell Lymphoma ◽  
Antigen Receptor ◽  
B Cell Lymphoma ◽  
T Cell Therapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document